Perhaps because of the inherent challenge in reconciling views based on medicine and economics, no government has been willing to leave health outcomes to the sole discretion of the market. Nevertheless, healthcare business is well-established and crucial to economic development given its implications for the future health and earning capacity of populations. Difficulties in measuring health, the unpredictability of illness and the presence of government financing alongside private insurance all contribute to a picture of overall complexity in the health industry. Through an approach rooted in economic and business-level data and analysis, EFB attempts to bring a fresh perspective, including:

  • According to recognised industry classifications, an overview of the health value chain from the production of pharmaceuticals, to human health activities in hospitals, residential care and social work activities related to health
  • A focus on sustainability-related developments in the health industry as regards the most relevant UN Sustainable development Goals (especially SDG#3, “Good health and wellbeing”, and SDG#12 “, Responsible consumption and production”), as well as industry-level climate impact and company-level sustainability efforts
  • Analysis of major geographic regions and salient issues such as the impact of Covid-19 or trends in project evaluation, as well as a look at intersecting industrial value chains such as food, tourism and energy